Overall conceptual framework for studying the genetics of autoimmune diseases following vaccination: A regulatory perspective

Samir Lababidi, Andrea Sutherland, Barbara Krasnicka, Richard A. Forshee, Steven A. Anderson

Research output: Contribution to journalReview article

Abstract

The US Vaccine Adverse Event Reporting System contains case reports of autoimmune diseases (ADs) occurring following vaccinations. ADs are rare and occur in unvaccinated people, making the potential association between vaccines and ADs challenging to evaluate. Developing mechanistic pathways that link genes, immune mediators, vaccine components and ADs would be helpful for hypothesis generation, enhancing theories of biologic plausibility and grouping rare autoimmune adverse events to increase the ability to detect and evaluate safety signals. Here, we propose a conceptual framework for investigating the genetics of ADs as safety signals following vaccination, potentially contributing to the identification of relevant biomarkers. We also discuss a study design that incorporates genetic information into postmarket clinical evaluation of autoimmune adverse events following vaccination.

Original languageEnglish (US)
Pages (from-to)1107-1120
Number of pages14
JournalBiomarkers in Medicine
Volume9
Issue number11
DOIs
StatePublished - Nov 2015

    Fingerprint

Keywords

  • biologic plausibility
  • genetics of autoimmune diseases
  • molecular biomarkers
  • rare adverse events
  • vaccine safety
  • vaccinomics

ASJC Scopus subject areas

  • Drug Discovery
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this